Stock Analysis on Net
Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Amgen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Accounts payable 2.08 1.64 2.41 2.23 2.26
Sales deductions 9.15 7.48 9.19 8.46 7.63
Income taxes payable 2.81 1.71 1.84 1.15 1.32
Employee compensation and benefits 1.45 1.42 1.69 1.77 1.74
Dividends payable 1.39 1.24 1.75 1.77 1.62
Accrued interest payable 0.94 0.96 0.72 0.00 0.00
Other 3.46 2.99 4.05 4.40 3.81
Accrued liabilities 19.21% 15.81% 19.23% 17.54% 16.11%
Current portion of long-term debt 3.87 1.49 2.44 0.14 0.14
Current liabilities 25.15% 18.93% 24.09% 19.92% 18.51%
Long-term debt, excluding current portion 61.57 65.02 57.36 54.32 52.26
Long-term deferred tax liabilities 1.76 2.42 0.02 0.00 0.00
Long-term tax liabilities 2.56 4.82 8.84 10.78 11.07
Other noncurrent liabilities 2.56 2.39 4.07 4.03 3.21
Noncurrent liabilities 68.45% 74.65% 70.29% 69.13% 66.54%
Total liabilities 93.60% 93.59% 94.38% 89.05% 85.05%
Common stock and additional paid-in capital; $0.0001 par value per share 36.51 34.04 49.93 52.47 50.52
Accumulated deficit -30.04 -27.33 -43.95 -40.22 -34.01
Accumulated other comprehensive loss -0.07 -0.30 -0.35 -1.30 -1.56
Stockholders’ equity 6.40% 6.41% 5.62% 10.95% 14.95%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Amgen Inc. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Amgen Inc. noncurrent liabilities as a percentage of total liabilities and stockholders’ equity increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Amgen Inc. total liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Amgen Inc. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.